Clinical Trial: Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac Surgery

U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07766109) titled 'Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac Surgery' on Aug. 10.

Brief Summary: SGLT-2 inhibitors are recommended treatments for managing heart failure patients. In cases of surgery, it is recommended to stop the treatment 3 days before surgery due to the risk of postoperative euglycemic diabetic ketoacidosis. However, several data suggest that it may be beneficial to maintain SGLT-2i treatment given the possibility of improving postoperative cardiovascular outcomes. Investigator team wish to conduct a randomized controlled trial to test the hypothesis that preoperative maintenance of SGLT-2i is superior to d...